APPLICATION
ANDA091418
TYPE
ANDA
ORIGINAL APPROVAL
2012-02-15
LATEST ACTION
2014-12-12
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
DOXORUBICIN HYDROCHLORIDEPrescription
DOXORUBICIN HYDROCHLORIDE 2MG/ML · INJECTABLE · INJECTION
Approval history
2014-12-12Labeling · Supplement 1 · standardAP
2012-02-15Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.